Assessment of percutaneous fine needle aspiration cytology as a technique to provide diagnostic and prognostic information in neuroblastoma
- 1 August 2000
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 36 (12) , 1544-1551
- https://doi.org/10.1016/s0959-8049(00)00146-5
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expressionBritish Journal of Cancer, 1997
- N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.Journal of Clinical Oncology, 1997
- Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas.Journal of Clinical Oncology, 1996
- CD44 -- A New Prognostic Marker for NeuroblastomaNew England Journal of Medicine, 1993
- Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.Journal of Clinical Oncology, 1993
- Association between High Levels of Expression of the TRK Gene and Favorable Outcome in Human NeuroblastomaNew England Journal of Medicine, 1993
- Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.Journal of Clinical Oncology, 1991
- N-myc gene amplification and other prognosis-associated factors in neuroblastomaJournal of Pediatric Surgery, 1990
- Association of Multiple Copies of the N-mycOncogene with Rapid Progression of NeuroblastomasNew England Journal of Medicine, 1985
- Histopathologic Prognostic Factors in Neuroblastic Tumors: Definition of Subtypes of Ganglioneuroblastoma and an Age-Linked Classification of NeuroblastomasJNCI Journal of the National Cancer Institute, 1984